Literature DB >> 31925489

Polymeric nanoassemblies for enrichment and detection of peptides and proteins in human breast milk.

Bo Zhao1, Jingjing Gao1, Mahalia A C Serrano1, Kathleen F Arcaro2, S Thayumanavan3,4,5, Richard W Vachet6,7,8.   

Abstract

Human breast milk is an understudied biological fluid that may be useful for early detection of breast cancer. Methods for enriching and detecting biomarkers in human breast milk, however, are not as well-developed as compared with other biological fluids. In this work, we demonstrate a new enrichment method based on polymeric nanoassemblies that is capable of enhancing the mass spectrometry-based detection of peptides and proteins in human breast milk. In this method, positively charged nanoassemblies are used to selectively deplete abundant proteins in milk based on electrostatic interactions, which simplifies the mixture and enhances detection of positively charged peptides and proteins. Negatively charged nanoassemblies are used in a subsequent enrichment step to further enhance the detection and quantification of trace-level peptides and proteins. Together the depletion and enrichment steps allow model biomarkers to be detected at low nM levels, which are close to instrumental limits of detection. This new method not only demonstrates the ability to detect proteins in human breast milk but also provides an alternative approach for targeted protein detection in complex biological matrices. Graphical abstract.

Entities:  

Keywords:  Biomarkers; Breast milk; Mass spectrometry; Nanomaterials; Protein enrichment

Mesh:

Substances:

Year:  2020        PMID: 31925489      PMCID: PMC7008079          DOI: 10.1007/s00216-019-02342-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  40 in total

Review 1.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

Review 2.  Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics.

Authors:  Sallie S Schneider; Roshanak Aslebagh; Armand G Ngounou Wetie; Susan R Sturgeon; Costel C Darie; Kathleen F Arcaro
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

3.  PeptideShaker enables reanalysis of MS-derived proteomics data sets.

Authors:  Marc Vaudel; Julia M Burkhart; René P Zahedi; Eystein Oveland; Frode S Berven; Albert Sickmann; Lennart Martens; Harald Barsnes
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

Review 4.  Molecularly imprinted polymers for the recognition of proteins: the state of the art.

Authors:  A Bossi; F Bonini; A P F Turner; S A Piletsky
Journal:  Biosens Bioelectron       Date:  2006-08-07       Impact factor: 10.618

Review 5.  Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers.

Authors:  Karen L Abbott; J Michael Pierce
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

Review 6.  Cancer biomarker detection: recent achievements and challenges.

Authors:  Li Wu; Xiaogang Qu
Journal:  Chem Soc Rev       Date:  2015-03-05       Impact factor: 54.564

7.  Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women.

Authors:  Chung M Wong; Douglas L Anderton; Sallie Smith-Schneider; Megan A Wing; Melissa C Greven; Kathleen F Arcaro
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

Review 8.  Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-An update covering the period 2011-2014.

Authors:  Chanida Puangpila; Erandi Mayadunne; Ziad El Rassi
Journal:  Electrophoresis       Date:  2014-11-24       Impact factor: 3.535

Review 9.  Human milk composition: nutrients and bioactive factors.

Authors:  Olivia Ballard; Ardythe L Morrow
Journal:  Pediatr Clin North Am       Date:  2013-02       Impact factor: 3.278

10.  Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges.

Authors:  Anna K Füzéry; Joshua Levin; Maria M Chan; Daniel W Chan
Journal:  Clin Proteomics       Date:  2013-10-02       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.